Practical Guidance for Implementing Predictive Biomarkers into Early Phase Clinical Studies

Abstract

The recent U.S. Food and Drug Administration (FDA) coapprovals of several therapeutic compounds and their companion diagnostic devices (FDA News Release, 2011, 2013) to identify patients who would benefit from treatment have led to considerable interest in incorporating predictive biomarkers in clinical studies. Yet, the translation of predictive biomarkers… (More)
DOI: 10.1155/2013/891391

Topics

3 Figures and Tables

Statistics

0102030201520162017
Citations per Year

Citation Velocity: 6

Averaging 6 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Marton2013PracticalGF, title={Practical Guidance for Implementing Predictive Biomarkers into Early Phase Clinical Studies}, author={M. Marton and Russell Weiner}, booktitle={BioMed research international}, year={2013} }